ANVRX
Price
$10.34
Change
+$0.15 (+1.47%)
Updated
Aug 7 closing price
Net Assets
585.3M
DODFX
Price
$61.95
Change
+$0.60 (+0.98%)
Updated
Aug 7 closing price
Net Assets
56.61B
Interact to see
Advertisement

ANVRX vs DODFX

Header iconANVRX vs DODFX Comparison
Open Charts ANVRX vs DODFXBanner chart's image
American Century Non-US Intrs Val R
Price$10.34
Change+$0.15 (+1.47%)
VolumeN/A
Net Assets585.3M
Dodge & Cox International Stock I
Price$61.95
Change+$0.60 (+0.98%)
VolumeN/A
Net Assets56.61B
ANVRX vs DODFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ANVRX vs. DODFX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVRX is a Hold and DODFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DODFX has more cash in the bank: 56.6B vs. ANVRX (585M). ANVRX (1.91) and DODFX (1.84) have matching dividends . ANVRX was incepted earlier than DODFX: ANVRX (6 years) vs DODFX (24 years). ANVRX (1.69) is less costly to investors than DODFX (0.62). ANVRX is a more actively managed with annual turnover of: 64.00 vs. DODFX (16.00). ANVRX (2500) and DODFX (2500) have matching initial minimum investment requirements. DODFX annual gain was more profitable for investors over the last year : 27.16 vs. ANVRX (10.94). DODFX return over 5 years is better than : 81.67 vs. ANVRX (41.47).
ANVRXDODFXANVRX / DODFX
Total Expense Ratio1.690.62273%
Annual Report Gross Expense Ratio1.690.62273%
Fund Existence6 years24 years-
Gain YTD27.37524.148113%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets585M56.6B1%
Annual Yield % from dividends1.911.84104%
Returns for 1 year10.9427.1640%
Returns for 3 years28.7650.1257%
Returns for 5 years41.4781.6751%
Returns for 10 yearsN/A60.32-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LEA96.020.82
+0.86%
Lear Corp
YMAB8.52N/A
N/A
Y-mAbs Therapeutics
FORLU11.54N/A
N/A
Four Leaf Acquisition Corp
CNTX0.70N/A
-0.14%
Context Therapeutics
STC67.69-0.21
-0.31%
Stewart Information Services Corp